Cancer, Sarcoidosis
Conditions
Keywords
sarcoidosis, cancer, paraneoplastic, treatment, outcome
Brief summary
The purpose of this study is to develop a clinical dataset of sarcoidosis patients with a diagnosis of cancer who are categorized by date of birth, sex, race/ethnicity, clinical information, laboratory and imaging information, time of sarcoidosis onset, cancer type and treatment, time of cancer diagnosis, stage and grade.
Interventions
None listed
Sponsors
University of Miami
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of Sarcoidosis following cancer * Granulomatous reaction must be proven by pathology
Exclusion criteria
. Aged younger than 18 years old.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pathology Proven Sarcoidosis In Patients with Cancer | up to 10 years | Number of Participants With Sarcoidosis Events as Assessed by Positive Granulomatous Reaction in the Biopsies of Lung, Mediastinal Lymph Nodes, or Other Organs After Cancer Diagnosis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cancer Cytogenetics and Sarcoidosis | up to 10 years | Number of Participants With Sarcoidosis Events as Assessed by Cancer Cytogenetic Profiles of Cancer. |
| Treatment Requirement of Sarcoidosis | up to 10 years | Number of Participants With Sarcoidosis Events as Assessed by Requirement of Treatment with Steroid or Other Anti-Sarcoid Medications in Patients with Cancer. |
Countries
United States
Outcome results
None listed